Gender-dependent Expression of ERβ in AEC Ⅱ of Fetal Mice Exposed to Arsenic and Estrogen Receptor Antagonist
Abstract
To determine the effects of arsenic and estrogen receptor antagonist (ICI182,780) on the expression of estrogen receptor beta (ERβ) in alveolar Ⅱ epithelial cells (AECⅡ) of female and male mice. Methods Nineteen or twenty day fetus mice were obtained through caesarean section of ICR mice. Purified AECⅡ cells were separated from the female and male fetus, respectively, and confirmed using immunofluorescence staining. The cells were exposed to sodium arsenite (NaAsO2) at a low, medium, or high dosage determined by MTT and cultured for 24 h. The NaAsO2 (5 μmol/L) exposed cells were compared with those treated (for 24 h) with dimethyl sulfoxide (DMSO) or ICI182,780 (1×10-4 mol/L). Apoptosis rates of the cells were measured by flow cytometry. Real-time fluorescence quantitative PCR method and Western blot technique were used to detect the expression ofERβmRNA and protein in AECⅡ. Results Purity of AECⅡ cells reached (87.0±2.5)%. NaAsO2 exposure was set at a concentration of 0.5 (low), 1.25 (medium), and 5 (high) μmol/L. The cells exposed to medium and high dosage of NaAsO2 had higher apoptosis rates than the blank controls (P<0.05), without sex differences. Female cells exposed to medium and high dosage of NaAsO2 had higher levels of expressions ofERβmRNA and protein than the blank controls (P<0.05) and male cells exposed to the same dosage of NaAsO2 (P<0.05). No significant differences were found in the expressions ofERβmRNA and protein between the exposed male cells and the blank controls. ICI182,780 lowered the expression levels ofERβmRNA and protein in the female exposed cells (P<0.01). Conclusion Arsenic exposure increases expressions of AECⅡ’s ERβ, more so in female cells than in male cells. This can be blocked by estrogen receptor antagonists.
Keywords: Fetal mice AECⅡ, Estrogen receptor β, Estrogen receptor antagonist, Sodium arsenite
Full Text:
PDFReferences
GOCHFELD M. Framework for gender differences in human and animal toxicology. Environ Res,2007,104(1):4-21.
KIM CF, JACKSON EL, WOOLFENDEN AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell,2005,121 (6);823-835.
NG JC, WANG J, SHRAIM A. A global health problem caused by arsenic from natural sources. Chemosphere, 2003, 52(9):1353-1359.
VAHTER M, AKESSON A, LIDEN C, et al. Gender differences in the disposition and toxicity of metals. Environ Res,2007,104(1) :85-95.
SHEN J, LIU J, XIE Y,et al. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol Sci,2007,95(2) ;313-320.
WALVEKAR RR. KANE SV, NADKARNI MS. et al.Chronic arsenic poisoning; a global health issue a report of multiple primary cancers. J Cutan Pathol, 2010, 34 ( 2) ; 203-206.
SCHWARTZ AG, PRYSAK GM, MURPHY V, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res, 2005, 11 (20) ; 7280-7287.
SONNENSCHEIN С, SOTO AM. An updated review of environmental estrogen and androgen mimics and antagonists. JSteroid Biochem Mol Biol, 1998, 65 ( 1/2/3/4/ 5/6);143-150.
MUELLER SO. KORACH KS. Mechanisms of estrogen receptor-mediated agonistic and antagonistic effects// METZLER M. Endocrine Disruptors-Part I . The Handbook of Environmental Chemistry. Springer. Berlin: 2001.3L: 1-25.
WUJP. CHANG LW, YAO HT. et al. Involvement of oxidative stress and activation of aryl hydrocarbon receptor in elevation of CYPlAl expression and activity in lung cells and tissues by arsenic: an in vitro and in vivo study. Toxicol Sci. 2009.107(2):385-393.
TOKAR EJ. DIWAN BA. WARD JM. et al. Carcinogenic effects of “whole-life” exposure to inorganic arsenic in CD1 mice. Toxicol Sci.2011,119( 1);73-83.
NEMENOFF RA. WINN RA. Role of nuclear receptors in lung tumourigenesis. Eur J Cancer.2005.41 (16):2561-2568.
Refbacks
- There are currently no refbacks.



